Effect of Exercise and Salvia officinalis on Postmenopausal Women

The Protective Effect of Aerobic Training with Salvia officinalis Consumption on Endothelial Function Indices in Postmenopausal Women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140415017288N10

Enrollment

Registered

2023-02-14

Start date

2023-04-04

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal Women. Unspecified menopausal and perimenopausal disorder

Interventions

Intervention 1: Control group: This group received three 100 mg starch tablets as a placebo during the 8-week intervention period. Intervention 2: Intervention group 1: Training group (in this group f

Eligibility

Sex/Gender

Female

Age

50 Years to 65 Years

Inclusion criteria

Inclusion criteria: Being menopausal Age range 50-65 years Inactive lifestyle (exercise less than 1 hour per week) Do not use the drug in 6 months Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Supplement use Diagnosis of other underlying diseases during the implementation of the protocol Not taking Salvia officinalis Use of estrogen and other androgens and steroids that affect estrogen receptors

Design outcomes

Primary

Measure	Time frame
Intercellular adhesion molecule (ICAM)-1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Soluble vascular cellular adhesion molecule 1 (sVCAM-1). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).	—

Secondary

Measure	Time frame
Endothelin-1 (ET-1). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;E-selectin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Nitric Oxide (NO). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).	—

Measure

Time frame

Endothelin-1 (ET-1). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;E-selectin. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).;Nitric Oxide (NO). Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods (by ELISA method).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Abdi

Islamic Azad University

a.abdi@iauamol.ac.ir+98 11 4321 7124

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026